p776

General Information


DRACP ID  DRACP00317

Peptide Name   p776

Sequence  GVGSPYVSRLLGICL

Sequence Length  15

UniProt ID  P04626  O18735  P06494  P70424 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
Tumor cell line Tumor Carcinoma Not available ELISA assay Not available 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Disrupting tumor-mediated mechanisms suppressing host immunity

Nature  Anticancer; Antitumor



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00317

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C69H116N18O19S

Absent amino acids  ADEFHKMNQTW

Common amino acids  GL

Mass  178375

Pl  8.53

Basic residues  1

Acidic residues  0

Hydrophobic residues  6

Net charge  1

Boman Index  1000

Hydrophobicity  110.67

Aliphatic Index  142.67

Half Life 
  Mammalian: 4.4 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  1490

Absorbance 280nm  106.43

Polar residues  7

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 21928125

Title  Ontak reduces the immunosuppressive tumor environment and enhances successful therapeutic vaccination in HER-2/neu-tolerant mice

Doi 10.1007/s00262-011-1113-4

Year  2012

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.